logo
  

Macellum Sees Urgent Need For Change In Kohl's Board - Quick Facts

Macellum Advisors GP, a long-term holder of nearly 5% of the outstanding common shares of Kohl's Corp. (KSS), issued an open letter to fellow shareholders regarding the need for an immediate and targeted refresh of the Board.

"In our view, the Board and, more specifically, the Shadow Board is failing to adequately support Kohl's senior management, which has resulted in the destruction of billions of dollars of shareholder value recently and perpetual stagnation over the long-term," Macellum Advisors GP, LLC stated.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT